N/A
Completed N=161
Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors
Source: ClinicalTrials.gov NCT02694640 ↗Enrolled (actual)
161
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcomePrimary: Physical Activity — 145.83; 159.86; 172.94; 120.81 min/week — p=<.05
Summary
Exercise adoption enhances well-being and recovery from breast cancer. Researchers trained American Cancer Society volunteers to provide exercise counseling to breast cancer survivors and the survivors increased their exercise in the short-term. This RCT examines the effects of three maintenance conditions on survivors' exercise participation at longer follow-ups. The cost-effectiveness of the three groups will be examined to guide implementation of this peer mentoring approach in community-based organizations.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Physical Activity |
145.83; 159.86; 172.94; 120.81; 137.16; 135.00 | <.05 sig |
| PRIMARY Min/Week Objectively Measured Moderate-to-vigorous Physical Activity |
46.43; 82.17; 54.62; 61.90; 68.75; 49.95 | <.05 sig |
| SECONDARY Breast Cancer Quality of Life |
24.72; 24.86; 24.76; 24.66; 24.88; 25.12 | — |
| SECONDARY Fatigue |
40.91; 42.02; 41.79; 41.33; 41.66; 41.35 | — |
| SECONDARY Mood |
8.52; 8.82; 7.71; 7.73; 5.12; 7.59 | — |
Eligibility Criteria
Inclusion Criteria
Women aged 21 years or over will be eligible if they:
- Have been diagnosed in the past 5 years with Stage 0-3 breast cancer.
- Are able to read and speak English.
- Are ambulatory.
- Are sedentary (i.e., do not meet recommendations for moderate-intensity PA [30 minutes/ day or more for at least 5 days/ week] or vigorous-intensity PA [20 minutes/day or more for at least 3 days/week]
- Are able to walk unassisted.
- Have access to a telephone.
Exclusion Criteria
Women with:
- More advanced disease (Stage 4).
- Medical or psychiatric problems (e.g., substance abuse, coronary artery disease, peripheral vascular disease, diabetes, and orthopedic problems) that may interfere with protocol adherence will not be included.
- Participants will be asked to provide consent for medical chart review to extract disease and treatment variables. Eligible participants will obtain medical clearance from their physicians.
Data sourced from ClinicalTrials.gov (NCT02694640). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.